Cardiomyopathy epidemiology and demographics: Difference between revisions
Lina Yaqoub (talk | contribs) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cardiomyopathy}} | {{Cardiomyopathy}} | ||
{{CMG}} | |||
==Overview== | |||
==Cardiomyopathy Epidemiology and Demographics== | |||
Incidence and prevalence differ based on cause. | Incidence and prevalence differ based on cause. | ||
* The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized. | * The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized. | ||
* The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 200 per 100,000 of the adult population. | |||
* The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least | |||
* RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions. | * RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions. | ||
==References== | ==References== | ||
Revision as of 14:49, 6 January 2019
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy epidemiology and demographics |
|
Risk calculators and risk factors for Cardiomyopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cardiomyopathy Epidemiology and Demographics
Incidence and prevalence differ based on cause.
- The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized.
- The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 200 per 100,000 of the adult population.
- RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions.
References
Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997; 336:267.
Basso C, Corrado D, Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009; 373:1289.
Template:Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997; 336:267. Basso C, Corrado D, Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009; 373:1289. Template:WS Template:Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331:1564.